Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma
The present study aimed to evaluate the efficacy of three-year subcutaneous SQ-standardized specific immunotherapy (SCIT) in house dust mite (HDM)-allergic children with asthma. Ninety children with allergic asthma to HDMs, with or without allergic rhinitis, were randomly divided into two groups, th...
Main Authors: | HUI, YU, LI, LING, QIAN, JUN, GUO, YUN, ZHANG, XILIAN, ZHANG, XIAOJUAN |
---|---|
Format: | Online |
Language: | English |
Published: |
D.A. Spandidos
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919950/ |
Similar Items
-
Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting
by: Hahn-Pedersen, J., et al.
Published: (2016) -
Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
by: Kim, Seon-Tae
Published: (2015) -
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
by: Rieker-Schwienbacher, Juliane, et al.
Published: (2013) -
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
by: Trebuchon, Florence, et al.
Published: (2014) -
Immunotherapy – 2077. Allergen specific immunotherapy in allergic conjuntivitis due to dust mite
by: Pawar, Sanjay
Published: (2013)